volume 45, issue 3, P459-467 2019
DOI: 10.1590/s1677-5538.ibju.2018.0305
View full text
|
|
Share

Abstract: Purpose: 68Ga-PSMA PET/CT imaging is a promising modality for the staging of recurrent prostate cancer (PCa). Current evidence suggests limited diagnostic value of the 68Ga-PSMA PET/CT in PSA-levels ≤0.3ng/mL. Experimental data have demonstrated an increase in PSMA-expression in PCa metastases by androgen deprivation in vitro. The aim of the current study was to investigate a possible enhancing effect of PSMA with low-dose androgen deprivation in patients with BCR and low PSA-levels.Materials and Methods:Five …

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
8
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals